About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Texas | 655 Studies

Clinical Trials Pancreatic CancerTexas

Pancreatic Cancer Clinical Trials in Texas

Find 655 clinical trials for pancreatic cancer near Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 521-540 of 655 trials

TerminatedCetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic CancerEligible patients with metastatic pancreatic cancer will be treated with dual agent monoclonal antibody consisting of cetuximab and bevacizumab alone or in combination with…NCT00326911·Jonesboro, Arkansas and 15 others Active not recruitingA Registry Study of NanoKnife IRE for Stage 3 Pancreatic CancerThis multicenter, observational study will evaluate the effectiveness and safety of the NanoKnife System when used for the ablation of Stage 3 pancreatic adenocarcinoma (Stage 3…NCT03899649·La Jolla, California and 13 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionThis is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor…NCT06756035·Denver, Colorado and 8 others

Active not recruitingAn Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibThe purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer therapy alone to subjects from an…NCT02955940·Santa Monica, California and 8 others

CompletedA Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid TumorsThe study consists of 2 parts.NCT04247126·Gilbert, Arizona and 15 others

Active not recruitingTesting the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic CancerThis phase I trial studies the side effects and best dose of anetumab ravtansine when given together with nivolumab, ipilimumab and gemcitabine hydrochloride in treating patients…NCT03816358·Birmingham, Alabama and 44 others

Active not recruitingResistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength StudyThis clinical trial studies the safety of a real-time tele-exercise resistance training (training done using a tablet) in maintaining skeletal muscle, strength, physical function…NCT04837118·Houston, Texas

CompletedDose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid TumorsThe purpose of this study is to determine if TH-302, in combination with A) Gemcitabine, or B) Docetaxel or C) Pemetrexed methotrexate, are safe and effective in the treatment of…NCT00743379·Scottsdale, Arizona and 10 others

UnknownA Study to Assess PV-10 Chemoablation of Cancer of the LiverThis open-label study will evaluate the safety, tolerability, pharmacokinetics and effect on tumor growth following a single intralesional injection of PV-10 in subjects with…NCT00986661·San Diego, California and 4 others

TerminatedStudy of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of PancreasThe goal is to assess survival and patterns of failure in patients treated with Gemzar-based chemoradiation and TNP-470 for locally advanced adenocarcinoma of the pancreas.NCT00038701·Houston, Texas

RecruitingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsThis study is to evaluate the safety, tolerability, and PK profiles of Elironrasib and Daraxonrasib as monotherapies and combination therapy in patients with KRAS G12C-mutated…NCT06128551·Duarte, California and 55 others

CompletedA Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)This was an open-label, nonrandomized, Phase 1/2 study designed to determine the safety, tolerability, and efficacy of epacadostat when given in combination with pembrolizumab and…NCT03085914·Phoenix, Arizona and 15 others

CompletedA Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA MutationThe purpose of this study is to determine whether oral rucaparib is effective in the treatment of patients with locally advanced or metastatic pancreatic cancer and a known…NCT02042378·Los Angeles, California and 7 others

RecruitingRelacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaThis is a 2-part, Phase 2 study to evaluate the safety, tolerability, dosing, pharmacokinetics (PK), and efficacy of relacorilant in combination with nab-paclitaxel and…NCT07259317·Scottsdale, Arizona and 19 others

CompletedDNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.NCT04825834·Homewood, Alabama and 56 others

CompletedPhase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC PatientsThis is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with…NCT06119217·Tucson, Arizona and 63 others

TerminatedA Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsThis study is about TAK-500, given either alone or with pembrolizumab, in adults with select locally advanced or metastatic solid tumors.NCT05070247·Birmingham, Alabama and 11 others

CompletedA Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.To evaluate the safety of OncoSil™ in a patient population undergoing standard chemotherapy treatment for pancreatic cancer.NCT03076216·Los Angeles, California and 3 others

UnknownA Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck CancersThe project is designed to test new biomarkers that are more sensitive than the current standard in detecting injury to the proximal kidney tubule and will establish better…NCT01936376·Boston, Massachusetts and 2 others

Recruiting[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsThis is a multi-center, open-label, single-arm, Phase 1/2 study designed to evaluate the safety, radiation dosimetry, and preliminary diagnostic performance of \[18F\]FPyQCP in…NCT07432633·Dallas, Texas

PreviousPage 27 of 33Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia